Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years

Francesco, Maria Antonia De; Caracciolo, Sonia; Bonfanti, Carlo; Manca, N.

doi:10.1007/s10156-012-0527-z

Cited by 62 publications

(49 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Vajinit ön tanılı kadın hastalardan genital U.urealyticum ve M.hominis sıklığı ve antimikrobiyal duyarlılıkları belirlenmesi ile ilgili çeşitli çalışmalar yapılmıştır (2,6,7,9,15,18) . Zhu ve ark.…”

Section: Bulgularunclassified

“…(18) 'nın genital infeksiyon şüphesi olan 3,306 kadın hastada genital U.urealyticum ve M.hominis sıklığını ve antimikrobiyal duyarlılıklarını Mycoplasma stripi (Zhuhai Lizhu, Guangzhou, Çin) kullanarak değerlendirdikleri çalışmada vajen örnekle-rinden en sık U.urealyticum (% 46.5), ikinci sıklık-ta U.urealyticum ve M.hominis (% 13.9), üçüncü sıklıkta ise M.hominis (% 1.7) izole edildiği bildirilmiştir. Yine İtalya'da Mycoplasma IST 2 test kiti kullanılarak yapılan bir çalışmada genital Mycoplasma prevalansı % 18.6 olarak raporlanmıştır (6) . Turan ve ark.…”

Section: Bulgularunclassified

“…Yapılan çalışmalarda, doksisiklinin Mycoplasma infeksiyonları için en aktif tetrasiklin olduğu bulunmuştur (6,15,18) . Çalışmamızda da benzer şekilde U.urealyticum ve M.hominis'in duyarlılığının en yüksek olduğu tetrasiklin grubu antibiyotiğin doksisiklin olduğu saptanmıştır.…”

Section: Bulgularunclassified

“…Gebelik gibi tetrasiklinlerin ve kinolonların kontrendike olduğu durumlarda tedavide makrolidler tercih edilebilmekte fakat makrolidlere de direnç oranlarının özellikle mikst infeksiyonlarda yüksek olması tedavi seçeneklerini kısıtlı hale getirmektedir (11) . Makrolidler arasında josamisin ve klaritromisin üreaplazmalara karşı en aktif ajanlar olarak raporlanmıştır (6) . Josamisin aynı zamanda Mycoplasma'ya karşı da aktif olduğundan, mikst infeksiyonlarda, özellikle hamile kadınlar ve yenidoğanlarda, eritromisin ve tetrasiklinlere alternatif olabileceği belirtilmiştir (6) .…”

Section: Bulgularunclassified

“…Makrolidler arasında josamisin ve klaritromisin üreaplazmalara karşı en aktif ajanlar olarak raporlanmıştır (6) . Josamisin aynı zamanda Mycoplasma'ya karşı da aktif olduğundan, mikst infeksiyonlarda, özellikle hamile kadınlar ve yenidoğanlarda, eritromisin ve tetrasiklinlere alternatif olabileceği belirtilmiştir (6) . Ancak ülkemizde pristinamisin ve josamisin preparatı bulunmamaktadır.…”

Section: Bulgularunclassified

See 4 more Smart Citations

The Prevalence and Antibiotic Resistance Profiles of Mycoplasma hominis and Ureaplasma urealyticum at a University Hospital

Meral¹,

Altun²,

Arıbaş³

2014

Ankem Derg

View full text Add to dashboard Cite

ÖZET Ürogenital sistemden en sık izole edilen mikoplazmalar Mycoplasma hominis ve siprofloksasine % 75.8, ofloksasine % 47.8, eritromisine % 22, klaritromisine % 19.7, azitromisine % 15.6, josamisine % 8.4, pristinamisine % 6.5, tetrasikline % 3.2, doksisikline % 2 direnç saptanmıştır. M.hominis suşlarında ise eritromisine % 95.9, klaritromisine % 89.1, siprofloksasine % 87.1, ofloksasine % 87.1, azitromisine % 83, josamisine % 25.8, pristinamisine % 15, tetrasikline % 12.3, doksisikline % 6.8 : Ciprofloxacin 75.8 %, ofloxacin 47.8 %, erythromycin 22 %, clarithromycin 19.7 %, azithromycin 15.6 %, josamycin 8.4 %, pristinamycin 6.5 %, tetracycline

show abstract

Section: Bulgularunclassified

See 3 more Smart Citations

The Prevalence and Antibiotic Resistance Profiles of Mycoplasma hominis and Ureaplasma urealyticum at a University Hospital

Meral¹,

Altun²,

Arıbaş³

2014

Ankem Derg

View full text Add to dashboard Cite

show abstract

Epidemiological investigation and antimicrobial susceptibility analysis of mycoplasma in patients with genital manifestations

Liu

Guo

et al. 2019

Clinical Laboratory Analysis

View full text Add to dashboard Cite

Background The aim of this study was to investigate the infection and antimicrobial resistance of Ureaplasma urealyticum and Mycoplasma hominis in patients with genitourinary symptoms among Hakka population in Meizhou, China. Methods A total of 12 633 females and 3315 males who presented urogenital symptoms and were subjected to mycoplasma tests from 2014 to 2018 were enrolled in this study. The mycoplasma detection and antimicrobial susceptibility were tested using the Mycoplasma ID/AST kit. Results The total incidence of mycoplasma infection, as well as the incidence of U urealyticum in Hakka population was annually increasing from 2014 to 2018. The total incidences and U urealyticum infection were more prevalent in females than males. Higher positive rate of mycoplasmas infection was observed in women aged 16‐20 (50.9%) and men aged 26‐30 (25.4%). The occurrence of antimicrobial resistance of mycoplasma to antibacterial agents remained relatively similar in the past five years. Ureaplasma urealyticum infection, M hominis infection, and co‐infection of resistance to levofloxacin, erythromycin, ciprofloxacin, ofloxacin, roxithromycin, azithromycin, clarithromycin, and sparfloxacin were dramatically higher in females than in males. Conclusion Our findings indicate a high burden of mycoplasmas infection and antimicrobial resistance of mycoplasmas infection among females, and josamycin and minocycline may be recommended as the primary choice in clinical treatment of anti‐mycoplasmas.

show abstract

Emerging role for Ureaplasma parvum serovar 3: Active infection in women with silent high‐risk human papillomavirus and in women with idiopathic infertility

Zanotta

Campisciano

Morassut

et al. 2019

Journal Cellular Physiology

View full text Add to dashboard Cite

Recently, there are controversial opinions on the presence of Mycoplasmas/Ureaplasmas as colonizers or pathogens, and on the use of a targeted therapy. This study aimed to characterize Mycoplasmas/Ureaplasmas infections in reproductive age women, including the acquisition of sexually transmitted (ST) pathogens and poor birth outcomes. A total of 646 healthy Italian women fulfilled the inclusion criteria including 521 infertile women, 65 pregnant women, and 60 fertile women with identified risk factors and symptomatic for vaginitis/cervicitis. Multiplex and quantitative molecular techniques and direct automatic DNA sequencing were performed to assess the genome structure of Mycoplasma/Ureaplasma species and ST infected pathogens. Ureaplasma parvum serovar 3 represented the predominant colonizer of the urogenital tract of this series and the unique species significantly associated with ST pathogens coinfection (p < 0.01). U. parvum load >104 bacteria/ml, suggestive of active infection, has been measured only in asymptomatic high‐risk human papillomavirus infected women (24.3%) and in 40% of women with idiopathic infertility. To note, 16% of the follicular fluid from these idiopathic women resulted infected with U. parvum. In conclusion, the present study focused the attention on U. parvum serovar 3 as emerging microorganism in sexually active women that may have the benefit of targeted therapy.

show abstract

Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years

Cited by 62 publications

References 23 publications

The Prevalence and Antibiotic Resistance Profiles of Mycoplasma hominis and Ureaplasma urealyticum at a University Hospital

The Prevalence and Antibiotic Resistance Profiles of Mycoplasma hominis and Ureaplasma urealyticum at a University Hospital

Epidemiological investigation and antimicrobial susceptibility analysis of mycoplasma in patients with genital manifestations

Emerging role for Ureaplasma parvum serovar 3: Active infection in women with silent high‐risk human papillomavirus and in women with idiopathic infertility

Contact Info

Product

Resources

About